Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland; Neglected Infectious Diseases, Global Health, Infectious Diseases, Bill and Melinda Gates Foundation, Seattle, Washington; Departments of Global Health, Medicine, Pediatrics, Epidemiology, University of Washington, Seattle, Washington.
Am J Trop Med Hyg. 2014 Jan;90(1):54-60. doi: 10.4269/ajtmh.13-0467.
In March 2013, the National Institute of Allergy and Infectious Diseases and the Bill and Melinda Gates Foundation co-sponsored a meeting entitled "Schistosomiasis Elimination Strategy and Potential Role of a Vaccine in Achieving Global Health Goals" to discuss the potential role of schistosomiasis vaccines and other tools in the context of schistosomiasis control and elimination strategies. It was concluded that although schistosomiasis elimination in some focal areas may be achievable through current mass drug administration programs, global control and elimination will face several significant scientific and operational challenges, and will require an integrated approach with other, additional interventions. These challenges include vector (snail) control; environmental modification; water, sanitation, and hygiene; and other future innovative tools such as vaccines. Defining a clear product development plan that reflects a vaccine strategy as complementary to the existing control programs to combat different forms of schistosomiasis will be important to develop a vaccine effectively.
2013 年 3 月,美国过敏和传染病研究所与比尔及梅林达·盖茨基金会共同主办了一次题为“血吸虫病消除策略和疫苗在实现全球健康目标方面的潜在作用”的会议,旨在讨论血吸虫病疫苗和其他工具在血吸虫病控制和消除策略方面的潜在作用。会议得出结论,尽管在一些重点地区通过当前的大规模药物治疗方案可能实现血吸虫病消除,但全球控制和消除将面临一些重大的科学和业务挑战,需要采取综合办法,结合其他补充干预措施。这些挑战包括病媒(蜗牛)控制;环境改造;水、环境卫生和个人卫生;以及其他未来的创新工具,如疫苗。制定明确的产品开发计划,反映疫苗战略是对现有控制规划的补充,以防治不同形式的血吸虫病,这对于有效研制疫苗非常重要。